Brief: Geneuro and Servier announce ANGEL-MS extension clinical study in multiple sclerosis

Geneuro SA

07/12/2016 06:31

Dec 7 (Reuters) - Geneuro SA  GNRO.PA :  
    * Geneuro and Servier announce ANGEL-MS extension clinical 
study in multiple sclerosis 
    * ANGEL-MS will be conducted in parallel with any Phase III 
studies that might be launched based on results of CHANGE-MS 
study 
    * Geneuro and Servier announce ANGEL-MS extension clinical 
study in multiple sclerosis 
    * Announces setting-up of ANGEL-MS, a long-term extension 
study for patients with multiple sclerosis (ms) and treated with 
GNBAC1 
 
Source text for Eikon:  ID:nBw7xSXmKa  
Further company coverage:  GNRO.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))